Johnson & Johnson

Moderna

AbbVie Inc.

American Red Cross

Gilead Sciences, Inc.

Arvita Tripati

VP operator. EIR. 30+ regulated AI products shipped.

Cohort 2

Cohort 1

Your product works. Your buyer liked the demo. So why did the deal go quiet? Often it's not the product, the pricing, or the competition. It's the messaging. This 3-minute scorecard tests whether messaging is your bottleneck covering 15 questions across five dimensions: clarity, buyer relevance, proof, trust, and conversion narrative. Most founders score 38-43 on their first attempt. Take it, find the gap, and fix the right problem.

Enterprise Messaging Scorecard


Stop losing deals because your product team doesn't know what healthcare buyers need to see. Build the evidence that gets contracts signed.

I make healthtech products buyable.

VP operator. EIR. 30+ regulated products shipped. AliveCor, LabCorp, Vineti

You built something that works. A pharma, clinic, CRO, or payer ran a pilot. The champion loved it. Then everything went quiet.Most founders assume this is a sales problem. It's not. It's a product problem.The buyer can't explain what you do internally. The documents procurement needs don't exist. The pilot proved the product works but didn't produce the evidence anyone needs to justify a contract.This course covers the product-side work that makes healthcare deals closeable. Over three weeks (6 live sessions, Mon/Wed), you'll work on your actual company and your actual deals, building the positioning, documentation, and evidence that pharmaceutical companies, clinics, CROs, health systems, and payers need to see before they sign.This is not a sales methodology course. No pipeline frameworks, no closing techniques. It's built from 18 years on the product and operations side of healthtech, watching good products fail to get bought because nobody on the product team understood what the buyer actually needed to see.

Great pilot. No contract. That's not a sales problem.

Your buyer can explain what you do without calling you

Your stalled deal has a clear path forward

Your product team owns the documents buyers actually need.

Structure pilots that lead to contracts, not just good results

Know whether this deal is worth your team's next 90 days

Not an idea, not a prototypesomething that works

You have a Product

Healthtech founders who've built a working product and can't figure out why buyers won't sign after a successful pilot.

Product and technical leaders at healthtech companies who are being pulled into sales and feel out of their depth on the commercial side.

Operators at early-stage healthtech companies who've need to build the product-side evidence that actually closes deals.

By the end of the lab, you will have a US-entry package made up of six practical artifacts. 

VP operator. EIR. 30+ regulated AI products shipped. AliveCor, LabCorp, Vineti, Korio, Clip Health

Healthtech founders are getting positive signals that never turn into revenue.Clinicians love the product. Advisors say the TAM is enormous. You might have a pilot running. And still, nothing is closing.So you fix the pitch. Hire a sales advisor. Ask another advisor which buyer to prioritize and get a different answer.The problem usually is not the pitch. It is that the market you chose cannot adopt what you built: not at this stage, not with your current evidence, not through the procurement and governance process your buyer actually requires.The buyer is not the user. The budget holder is not the champion. The evidence that excites a clinician is not the evidence that gets a contract signed.Healthcare-Market Fit gives you a framework to diagnose which market can actually buy, before you build the wrong proof strategy or spend another year in the wrong direction.

Healthcare has a hundred markets. Most founders pick the wrong one first.

Identify your first US buyer segment

Map your intended use and US-facing claims

Define the evidence US stakeholders will trust

Prepare for enterprise buyer review

Design your first US pilot so it can convert

Pressure-test your US entry story

Wellness &amp; Healthtech founders getting interest but not traction who aren't sure if the problem is the product, the pitch, or the market.

Medtech &amp; TechBio founders getting interest but not traction who aren't sure if the problem is the product, the pitch, or the market.

You have a product, prototype, or home-market sales who need to understand what US buyers, investors, partners, and regulators will expect.

Arvita Tripati makes healthtech products buyable.

Arvita Tripati

Courses

Sold. Build Your Healthtech or Life Sciences Pilot Conversion Playbook

Healthcare-Market Fit Lab (PMF for Healthcare & Life Sciences)

Resources

Enterprise Messaging Scorecard